Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.
about
Updating the OMERACT filter: implications for imaging and soluble biomarkersInsights into rheumatoid arthritis from use of MRI.Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis.MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16.Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy.Current imaging strategies in rheumatoid arthritisGreater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trialSystematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis.The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudyBone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective.Heading toward a modern imaging approach in juvenile idiopathic arthritis.Imaging in rheumatoid arthritis: options, uses and optimization.Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.Golimumab: A Review in Inflammatory Arthritis.Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review.Baseline MRI bone erosion predicts the subsequent radiographic progression in early rheumatoid arthritis patients who achieved sustained good clinical response.Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findings.Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging.Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.Anti-CCP antibodies are not a marker of severity in established rheumatoid arthritis: a magnetic resonance imaging study.MRI assessment of erosion repair in patients with long-standing rheumatoid arthritis receiving double-filtration plasmapheresis in addition to leflunomide and methotrexate: a randomized controlled trial.A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results frAssociation between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study.
P2860
Q27014889-0519EC53-D343-4E0A-9E56-1DF70C88DC09Q30698398-2FEF7FA7-0A79-4210-9FDC-520EC7734476Q35540004-99725650-46A4-4CE8-9D7F-C989DADBFDBAQ35605451-55C3DE66-19BF-43F8-864B-67A99A5CFB02Q35788326-930E86D5-4AFE-4641-9F99-A19609E198FFQ36337258-E648BA4F-286C-4025-AA52-0B91070565C6Q36732733-07EB8D72-5EC4-4BBC-AE4C-536BBEF1CA11Q37012723-6EF330BE-8BE2-4768-A251-9E232C12E458Q37587412-58905B21-EF42-42F7-B89B-E289E731C19AQ37715992-E8CC40AB-CB64-4EFA-8059-039E7E4B1BDCQ38050210-D226EAA2-65C1-429C-B0E7-14281F50CD66Q38194473-A9389153-3C2A-424D-8A65-18B953F48FF3Q38590254-81B2E1C3-0150-463F-881F-D9CE95055FF7Q38650245-1B9368CE-B279-4D3C-A819-F9FE1242859BQ38771878-740B7AE6-F420-43F2-AC4B-7A21BC3BD2DFQ38842603-199EE4EB-F9CC-4D06-9ADE-D8AE3BEFA70AQ38922606-52C1EF93-C369-423E-9BB4-93917A2E8E22Q46105872-32DBA093-E312-44BA-94CC-D51F41F317FFQ46916232-968045D1-7761-48DF-8B00-C9BB6A2A9936Q47094309-7B3FE1B3-8755-4DA8-B27D-FE69AF97CA69Q47875926-EB50595D-AC78-4E53-A883-B377399F65EFQ50127594-5386E40F-DF91-490F-9A8A-0F47CBA76A3DQ51759356-1629FFC4-ECAF-4F27-B6D4-943C2C0BB9CCQ54917641-6AB0169C-24CD-49BA-AA02-3541C5F9A214
P2860
Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@ast
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@en
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@en-gb
type
label
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@ast
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@en
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@en-gb
prefLabel
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@ast
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@en
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@en-gb
P2093
P2860
P356
P1476
Assessment by MRI of inflammat ...... sults of the GO-FORWARD trial.
@en
P2093
Edward C Keystone
Elizabeth C Hsia
Mahboob U Rahman
Mark C Genovese
Mikkel Østergaard
Weichun Xu
P2860
P304
P356
10.1136/ARD.2010.146068
P407
P577
2011-07-21T00:00:00Z
P5875
P6179
1007155489